key: cord-1026579-gnd78gqg authors: Lazartigues, Eric; Qadir, Mirza Muhammad Fahd; Mauvais-Jarvis, Franck title: Endocrine significance of SARS-CoV-2’s reliance on ACE2 date: 2020-07-11 journal: Endocrinology DOI: 10.1210/endocr/bqaa108 sha: 0f4fe510ff86e27731ef63805bf8c36403e31a6e doc_id: 1026579 cord_uid: gnd78gqg The current COVID-19 pandemic is the most disruptive event in the last 50 years with global impact on healthcare and world economies. It is caused by SARS-CoV-2, a coronavirus that uses angiotensin converting enzyme 2 (ACE2), as an entry point to the cells. ACE2 is a transmembrane carboxypeptidase and member of the renin-angiotensin system. This mini-review, summarizes the main findings regarding ACE2 expression and function in endocrine tissues. We discuss rapidly evolving knowledge on the potential role of ACE2 and SARS coronaviruses in endocrinology and the development of diabetes mellitus, hypogonadism, pituitary and thyroid diseases. Angiotensin Converting Enzyme type 2 (ACE2; [EC 3.4.17.23] ), was originally discovered in 2000 as a monocarboxypeptidase located on the cell surface and capable of cleaving the potent vasoconstritor Angiotensin (Ang)-II to the vasodilatory heptapeptide Ang-(1-7) (1, 2) . Beyond the renin-angiotensin system (RAS), ACE2 is also able to cleave other peptides such as apelin-13, apelin-36, des-Arg 9 -bradykinin, β-casomorphin, neocasomorphin and dynorphin (3) . As researchers started learning about ACE2, it was unexpectedly identified has been shown to play a pivotal role in the "compensatory axis" of the RAS (ACE2/Ang-(1-7)/Mas) (5) , opposing the effects of the classical axis (ACE/Ang-II/AT 1 receptor), with implications for blood pressure regulation (6) (7) (8) (9) , heart failure (10) (11) (12) , diabetes (13) (14) (15) (16) and obesity (17, 18) . In late 2019, ACE2 was again identified as a receptor for another coronavirus, SARS-CoV-2, responsible for the COVID-19 pandemic (19) . As of June 22 nd , at least 9 million individuals have been infected and 470,000 have died worldwide. Importantly, clinical reports suggest that pre-existing conditions such as hypertension, diabetes and obesity predispose to COVID-19 mortality (20) (21) . Here, we review the role of ACE2 as a SARS-CoV-2 receptor as it relates to endocrine diseases. A c c e p t e d M a n u s c r i p t Recent work has shown that ACE2, previously identified as an entry point for SARS-CoV (22) , is also the main receptor for SARS-CoV-2 (23) . The virus' entry into cells first relies on binding to ACE2 followed by priming of the viral spike protein, mainly by the serine protease TMPRSS2, which is necessary for the viral RNA to enter the cell. TMPRSS2 plays a critical role not only for SARS-CoV-2 infection but also for infection by other coronaviruses and influenza (24) . Importantly, for the infection to occur, the target cell must have both ACE2 and TMPRSS2 in proximity. Interestingly, TMPRSS2 is an androgen-regulated gene predominantly expressed in the prostate and with lower levels of expression in the lung, colon, liver, kidneys and pancreas. While most of TMPRSS2 is membrane-bound, it has also been identified in extracellular vesicles (25) , suggesting that the protease can reach out tissues beyond its expression sites. Overall, ACE2 and TMPRSS2 mRNA are expressed in the same organs in males and females (Figure 1 ), suggesting that they could potentially contribute to viral infection of these organs. In animals and humans including hypothalamus, pituitary, thyroid, gonads and pancreatic islets, ACE2 expression has been reported in most tissues, including those involved in endocrine functions ( Figure 1 ). Several groups have examined the implications of ACE2 deletion in murine endocrine organs and the overall beneficial effects of ACE2 gene therapy. Our group was the first to report ACE2 protein expression in the mouse brain, notably in hypothalamic regions associated with food intake and metabolic regulation (27). Mice exposed perinatally to a hypercaloric diet exhibited hypomethylation of the Ace2 gene, consistent with enhanced ACE2 activity in the hypothalamus (28) . We also observed that mice lacking ACE2 exhibited a lean phenotype while in contrast transgenic mice expressing human ACE2 selectively in neurons showed increased food intake and body weight, A c c e p t e d M a n u s c r i p t associated with fasting hyperglycemia and glucose intolerance. Interestingly, these metabolic abnormalities co-existed with a reduction in hypothalamic apelin levels, a peptide involved in the regulation of water and food intake, and could be partially normalized following icv infusion of apelin-13 (29) . Hypothalamic expression of ACE2 was also found to co-localize with vasopressin, oxytocin and GABAergic neurons, the latter being critical to the maintenance of an inhibitory input to pre-sympathetic neurons projecting to the kidney (30) supporting a compensatory mechanism to the development of hypertension. In the periphery, we also observed ACE2 expression in the exocrine and endocrine pancreas of the mouse with location in islets of Langerhans mostly restricted to glucagon-producing cells (13, 16, 31) , a finding also observed in human islets ( Figure 1 ) (32). However, a different pattern of expression was observed in rats, with co-localization to β-cells and somatostatinproducing δ-cells (33) , which suggests that expression could be species-specific. In the mouse, lack of ACE2 was associated with impaired first phase insulin secretion and glucose tolerance in both males and females (14,34) as well as decreased β-cell mass due to impaired β-cell proliferation (35) . In diabetic mouse models (13, 36) , ACE2 expression and activity were reduced in the pancreas while ACE2 gene therapy via injection into the pancreas improved fasting glycemia and glucose tolerance, increased β-cell proliferation, reduced β-cell apoptosis and increased islet insulin content, without affecting insulin sensitivity (13) . While a possible role for Ang-(1-7) has been suggested to mediate the paracrine effects of ACE2 (13, 32) , the detailed mechanism remains to be elucidated. Nevertheless, ACE2 appears to be critical to normal β-cell function and glucose homeostasis. ACE2 is expressed in the adipose tissue where it is thought to regulate local levels of Ang-II (17) . Exposing mice to a high fat diet was shown to exacerbate angiotensinogen expression and increase ACE2 mRNA possibly via PPAR activation (17) . However, in addition to a rise in blood pressure, the increase in Ang-II was associated with enhanced ADAM17-mediated A c c e p t e d M a n u s c r i p t ACE2 shedding from the cell surface, leading to a reduction in ACE2 activity on adipocytes in male (17) but not in female mice (18) . While deletion of ACE2 selectively in mouse adipocytes did not prevent the development of obesity in females, it resulted in a hypertensive phenotype (37) . Similarly, administration of 17β-estradiol to ovariectomized female mice was able to reduce obesity and hypertension in an ACE2-dependent manner (38) . ACE2 deficiency in mouse bone marrow cells was also reported to promote an inflammatory phenotype in the adipose tissue (39) and the anti-obesity effects of ACE2 have recently been suggested to be mediated by a browning of white adipose tissue (40) . ACE2 is expressed in the Leydig cells of the rat testis and in Leydig and Sertoli cells of the human testis with an upregulation occurring at puberty (41) . While these data suggest a role for ACE2 in testicular function, it was independent of the hypothalamo-pituitary-testicular axis. In summary, the above studies demonstrate that ACE2 plays a critical role in metabolic and endocrine regulation in rodents by alleviating overactivity of the classical RAS axis. Men are more frequently hospitalized, develop more severe complications, and are 1.5 to 2 times more likely to die from COVID-19 than women (42) (43) (44) (45) (46) (47) . Notably, ACE2 is located on the X chromosome (48) and human ACE2 promoter activity was also shown to be downregulated by chromosome Y genes, SRY and Sox3 in testis (49) . Since women have two copies compared to one in men, ACE2 may be regulated differently in men than in women. Yet, current studies suggest that ACE2 expression is not different between males and females ( Figure 1 ) and between younger or older subjects (50) . Therefore, ACE2 might A c c e p t e d M a n u s c r i p t not be responsible for the apparent gender differences in COVID-19 infection. Interestingly, TMPRSS2 is a direct androgen receptor target gene and its expression is increased by androgens in prostate cancer (51) , which could also have an impact on TMPRSS2 expression in men with COVID-19. Indeed, an Italian study reported that patients with prostate cancer receiving androgen depletion therapy had a significantly 4-fold lower risk of SARS-CoV-2 infection compared to patients who did not undergo this treatment (52) . While a differential regulation of ACE2 and TMPRSS2 in men and women may affect virus entry and pathogenicity, studies are needed to address these questions. SARS-CoV-2 may also affect the endocrine and exocrine pancreas as ACE2 and TMPRSS2 are expressed across the entire spectrum of pancreatic endocrine and exocrine cells ( Figure 1 ). In islet cells ACE2 and TMPRSS2 mRNA expression appears to be highest in subsets of beta and alpha cells. Exocrine, ductal and acinar cells also express ACE2 and TMPRSS2 mRNA ( Figure 1 ). In past decades, two other coronavirus outbreaks have crossed species and used the machinery of the endocrine system as a port of entry into cells. The first deadly coronavirus of 2002 (SARS-CoV) also used ACE2 (23) . As SARS-CoV-2 is closely related to SARS-CoV, knowledge accumulated from SARS can be useful to predict what may happen in patients who recover from COVID-19. In the mouse, we and others showed that ACE2 protein is expressed in the islet glucagon-producing α-cells (16) . Notably, human islets of Langerhans also express ACE2 protein in α-cells and a subset of other non ß-cells (32) Studies are needed to determine the potential effect of SARS-CoV-2 in islet dysfunction and its relation to diabetes pathogenesis. Testes are one of the original tissues where ACE2 expression was first described (1) and were found to be one of the sites with highest ACE2 expression in 3 independent RNA expression databases (Human Protein Atlas, FAMTOM5 and GETx), consistent with prior reports (55, 56) . It is also a site of TMPRSS2 expression (Figure 1 ). Viruses such as HIV, HBV, and mumps can cause orchitis and in some cases male infertility. The analysis of autopsy specimens of testes from six patients who died of SARS in Beijing, China, showed testicular involvement with orchitis (56) . Testes from the SARS cases exhibited extensive germ cell destruction, with few or no spermatozoon in the seminiferous tubules, as well as macrophage and lymphocyte infiltration compared to non-SARS specimens of testis. Although ACE2 is highly expressed in human testis, SARS-CoV RNA was not detected in the specimens, arguing for an immune-mediated orchitis rather than a direct effect of the virus (56) . Testosterone levels in patients with COVID-19 are not a reliable marker of A c c e p t e d M a n u s c r i p t testicular function as the acute and severe infection can suppress the hypothalamicpituitary-testicular axis and decrease circulating testosterone. However, an unpublished study in COVID-19 patients found that although testosterone levels did not statistically decrease in the COVID-19 group, a significant increase in serum luteinizing hormone (LH) concentrations and a decrease in serum ratio of testosterone:LH were observed (57) . This suggests that SARS-CoV-2 infection produces Leydig cell failure to produce enough testosterone leading to hypothalamic compensation. Whether this is a direct toxic effect of SARS-CoV-2 or secondary to systemic disease remains to be established. Therefore, monitoring of gonadal function seems warranted in men that recover from COVID-19 as a potential new cause of sterility. Altogether preclinical studies suggest that ACE2 plays a critical role in metabolic and endocrine regulation by preventing RAS overactivity. While the role of ACE2 in hormonal regulation, notably within the hypothalamus-pituitary axis, is unclear, the enzyme tends to protect against obesity, diabetes and hypertension. These authors have no conflict of interest to disclose. A novel angiotensinconverting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus ACE2/Ang-(1-7)/Mas pathway in the brain: The Axis of Good Angiotensin-converting enzyme 2: a new target for neurogenic hypertension Advances in the Biochemical and Functional Roles of Angiotensin Converting Enzyme 2 and Angiotensin-(1-7) in the Regulation of Cardiovascular Function Angiotensin-converting enzyme 2 as a novel target for gene therapy for hypertension Clinical Relevance and Role of Neuronal AT1 Receptors in ADAM17-Mediated ACE2 Shedding in Neurogenic Hypertension Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure: Insights Into the Endogenous Counter-Regulatory Pathway of the Renin-Angiotensin-Aldosterone System Brain-selective overexpression of angiotensin-converting enzyme 2 attenuates sympathetic nerve activity and enhances baroreflex function in chronic heart failure Deletion of Angiotensin-Converting Enzyme 2 Accelerates Pressure Overload-Induced Cardiac Dysfunction by Increasing Local Angiotensin II Angiotensin-I Converting Enzyme Type 2 (ACE2) Gene Therapy Improves Glycemic Control in Diabetic Mice The sweeter side of ACE2: physiological evidence for a role in diabetes Angiotensin converting enzyme 2: a new important player in the regulation of glycemia High-fat dietinduced glucose dysregulation is independent of changes in islet ACE2 in mice ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet Angiotensin converting enzyme 2 contributes to sex differences in the development of obesity hypertension in C57BL/6 mice Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody. Emerging microbes & infections Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19 Obesity and impaired metabolic health in patients with COVID-19 A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections Dexmedetomidine promotes breast cancer cell migration through Rab11-mediated secretion of exosomal TMPRSS2. Annals of translational medicine Decreased expression of angiotensin-converting enzyme 2 in pancreatic ductal adenocarcinoma is associated with tumor progression. The Tohoku journal of experimental medicine Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system Perinatal Exposure to Western Diet Programs Autonomic Dysfunction in the Male Offspring Apelin Icv Infusion Blunts Brain ACE2 Overexpression-mediated Metabolic Abnormalities in Mice ACE2 and ADAM17 Interaction Regulates the Activity of Presympathetic Neurons Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice -7)'s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1-2) Tissue-specific pattern of angiotensin-converting enzyme 2 expression in rat pancreas Loss of angiotensin-converting enzyme 2 leads to impaired glucose homeostasis in mice ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice Pancreatic angiotensinconverting enzyme 2 improves glycemia in angiotensin II-infused mice Adipocyte deficiency of ACE2 increases systolic blood pressures of obese female C57BL/6 mice Administration of 17β-estradiol to ovariectomized obese female mice reverses obesity-hypertension through an ACE2-dependent mechanism Deficiency of ACE2 in Bone-Marrow-Derived Cells Increases Expression of TNF-α in Adipose Stromal Cells and Augments Glucose Intolerance in Obese C57BL/6 Mice ACE2 exerts anti-obesity effect via stimulating brown adipose tissue and induction of browning in white adipose tissue The novel angiotensin-converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis Sex and gender: Modifiers of health, disease and medicine Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy Case Management Team KCfDC, Prevention. Coronavirus Disease-19: The First 7,755 Cases in the Republic of Korea Consortium atNC-R. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the Biological sex impacts COVID-19 outcomes PLoS Pathogens In Press The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases Similarities and differences of X and Y chromosome homologous genes, SRY and SOX3, in regulating the renin-angiotensin system promoters Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infectious diseases of poverty Prostate-localized and Androgen-regulated Expression of the Membrane-bound Serine Protease TMPRSS2. Cancer research Androgendeprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532) Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes Pancreatic injury patterns in patients with COVID-19 pneumonia Delayed clearance of SARS-CoV2 in male compared to female patients: High ACE2 expression in testes suggests possible existence of gender-specific viral reservoirs Orchitis: A Complication of Severe Acute Respiratory Syndrome (SARS)1 Effect of SARS-CoV-2 infection upon male gonadal function: A single center-based study Hypocortisolism in survivors of severe acute respiratory syndrome (SARS) Post-SARS sickness syndrome manifestations and endocrinopathy: how, why, and so what?* Pathology of the thyroid in severe acute respiratory syndrome Subacute thyroiditis after SARS-CoV-2 infection A subcellular map of the human proteome Proteomics. Tissue-based map of the human proteome. Science Towards a knowledge-based Human Protein Atlas Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression De Novo Prediction of Stem Cell Identity using Single-Cell Transcriptome Data A Single-Cell Transcriptome Atlas of the Human Pancreas Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes A Single-Cell Transcriptomic Map of the Human and Mouse Pancreas Reveals Inter-and Intra-cell Population Structure Integrating single-cell transcriptomic data across different conditions, technologies, and species Comprehensive Integration of Single-Cell Data A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t A c c e p t e d M a n u s c r i p t